The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders

Brooks M. Hybertson, Bifeng Gao, An Doan
ISSN / E-ISSN
— / —
DOI
10.2147/cpaa.s35078 ↗
Volume · Issue · Pages
6 · — · 19-19
Publisher
Dove Medical Press Ltd.
Article URL
https://doi.org/10.2147/cpaa.s35078 ↗
Article details
Unverified
Publication date (each date has its type and source)
01 Feb 2014
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date01 Feb 2014 OpenAlex

Keywords (as given): Nrf2 signaling; Nrf2; antioxidant response element; phase II enzymes; cytoprotective genes; chemoprevention; cancer chemotherapy resistance; degenerative diseases; immune disorders; dietary supplements; physical activity; disease prevention

HEC Status at Publication Not the journal's current status

HEC Status at PublicationNot conclusive
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Journal
Clinical Pharmacology: Advances and Applications
Publication date used
01 Feb 2014 (OpenAlex publication date)
Applicable HEC period
None recorded for this date
Category
—
Recognition status
Unknown (NO_PERIOD_FOR_DATE)
Source
—
Verification status
Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.